Lupin informs about press release

16 Jun 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, the Company having signed a license and supply agreement with Sino Universal Pharmaceuticals, for the commercialization of Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese market, for the treatment of chronic obstructive pulmonary disease.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2103.30 -8.70 (-0.41%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×